Rafferty Asset Management’s ALX Oncology ALXO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-156,876
| Closed | -$2.65M | – | 1130 |
|
|
2022
Q1 | $2.65M | Buy |
156,876
+49,896
| +47% | +$843K | 0.02% | 532 |
|
|
2021
Q4 | $2.3M | Buy |
+106,980
| New | +$2.3M | 0.01% | 607 |
|
|
2021
Q3 | – | Sell |
-43,721
| Closed | -$2.39M | – | 1259 |
|
|
2021
Q2 | $2.39M | Buy |
43,721
+538
| +1% | +$29.4K | 0.02% | 627 |
|
|
2021
Q1 | $3.18M | Buy |
43,183
+39,982
| +1,249% | +$2.95M | 0.02% | 452 |
|
|
2020
Q4 | $276K | Buy |
+3,201
| New | +$276K | ﹤0.01% | 850 |
|